Tumor-Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma (Q93074359)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

title

Tumor-Derived Peptidoglycan Recognition Protein 2 Predicts Survival and Antitumor Immune Responses in Hepatocellular Carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

main subject

hepatocellular carcinoma

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Ming Shi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

author name string

Zongyi Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Jia Feng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Li Xiao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Xi Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Yuanfei Yao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Yiqun Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Yu Tang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Shuai Zhang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Min Lu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

Yu Qian

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

publication date

3 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

3 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31479523 AND SRC:MED&resulttype=core&format=json

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

3 May 2020

cites work

1 reference

7 January 2021

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

1 reference

7 January 2021

Innate immune signaling and regulation in cancer immunotherapy

1 reference

7 January 2021

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance

1 reference

7 January 2021

Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity

1 reference

7 January 2021

Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation.

1 reference

7 January 2021

STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

1 reference

7 January 2021

Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth

1 reference

7 January 2021

The host STING pathway at the interface of cancer and immunity

1 reference

7 January 2021

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

1 reference

7 January 2021

Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway

1 reference

7 January 2021

Differential expression of peptidoglycan recognition protein 2 in the skin and liver requires different transcription factors

1 reference

7 January 2021

Peptidoglycan recognition protein 2 (N-acetylmuramoyl-L-Ala amidase) is induced in keratinocytes by bacteria through the p38 kinase pathway

1 reference

7 January 2021

Identification of serum N-acetylmuramoyl-l-alanine amidase as liver peptidoglycan recognition protein 2.

1 reference

7 January 2021

Human Peptidoglycan Recognition Protein-L Is an N-Acetylmuramoyl-L-alanine Amidase

1 reference

7 January 2021

Characterization of Human Serum N-Acetylmuramyl-L-alanine Amidase Purified by Affinity Chromatography

1 reference

7 January 2021

Sex-dependent alterations in motor and anxiety-like behavior of aged bacterial peptidoglycan sensing molecule 2 knockout mice.

1 reference

7 January 2021

Innate immune responses in peptidoglycan recognition protein L-deficient mice

1 reference

7 January 2021

Peptidoglycan recognition protein genes and risk of Parkinson's disease

1 reference

7 January 2021

Rapid detection of mycoplasma contamination in cell cultures using SYBR Green-based real-time polymerase chain reaction

1 reference

7 January 2021

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

1 reference

7 January 2021

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

1 reference

7 January 2021

Human breast tumor-infiltrating CD8 T cells retain polyfunctionality despite PD-1 expression

1 reference

7 January 2021

HLA‐A2‐restricted glypican‐3 peptide‐specific CTL clones induced by peptide vaccine show high avidity and antigen‐specific killing activity against tumor cells

1 reference

7 January 2021

Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes

1 reference

7 January 2021

Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma

1 reference

7 January 2021

Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain

1 reference

7 January 2021

Complement as a regulator of adaptive immunity

1 reference

7 January 2021

Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets

1 reference

7 January 2021

Neutrophil trails guide influenza-specific CD8⁺ T cells in the airways

1 reference

7 January 2021

NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control

1 reference

7 January 2021

Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer.

1 reference

7 January 2021

Peptidoglycan recognition proteins: modulators of the microbiome and inflammation

1 reference

7 January 2021